Cue Biopharma, Inc. (CUE)
NASDAQ: CUE · Real-Time Price · USD
27.01
+0.36 (1.35%)
At close: Aug 6, 2026, 4:00 PM EDT
26.94
-0.07 (-0.26%)
After-hours: Aug 6, 2026, 7:34 PM EDT
Cue Biopharma Employees
Cue Biopharma had 29 employees as of December 31, 2025. The number of employees decreased by 12 or -29.27% compared to the previous year.
Employees
29
Change (1Y)
-12
Growth (1Y)
-29.27%
Revenue / Employee
$1,128,655
Profits / Employee
-$673,207
Market Cap
113.45M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 29 | -12 | -29.27% | 29 | 0 |
| Dec 31, 2024 | 41 | -12 | -22.64% | 41 | 0 |
| Dec 31, 2023 | 53 | 1 | 1.92% | 53 | 0 |
| Dec 31, 2022 | 52 | -7 | -11.86% | 51 | 1 |
| Dec 31, 2021 | 59 | 7 | 13.46% | 57 | 2 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Seer, Inc. | 124 |
| Fractyl Health | 100 |
| enGene Therapeutics | 82 |
| Rani Therapeutics Holdings | 71 |
| Vivani Medical | 42 |
| ProMIS Neurosciences | 11 |
| Coya Therapeutics | 8 |
| Anixa Biosciences | 4 |
CUE News
- 3 days ago - Cue Biopharma appoints James Ahlers as CFO - TheFly
- 3 days ago - Cue Biopharma Announces Appointment of James M. Ahlers as Chief Financial Officer and CUE-221 Investigational New Drug Submission - GlobeNewsWire
- 24 days ago - Cue Biopharma appoints Dominic Borie as chief medical officer - TheFly
- 24 days ago - Cue Biopharma Appoints Dominic Borie, M.D., Ph.D., as Chief Medical Officer and Head of Research & Development - GlobeNewsWire
- 27 days ago - Cue Biopharma to sell 1.418M shares at $33.21 in private placement - TheFly
- 27 days ago - Cue Biopharma Announces $50.0 Million Private Placement - GlobeNewsWire
- 7 weeks ago - Cue Biopharma files to sell 551,724 shares of common stock for holders - TheFly
- 7 weeks ago - Cue Biopharma Registration statement: Registration filing - Filings